This half-day virtual workshop features FDA expert presentations and audience Q&A on bioequivalence (BE) approaches for topical and transdermal generic drug products. The focus on modernizing BE approaches is crucial for enhancing the development of generic drugs in these categories. This workshop may provide valuable insights for manufacturers and developers looking to navigate the complexities of regulatory requirements and improve their product offerings in the competitive generic market.
Source: fda.gov · Image: SDI, Samarra – Dec 21, 2019 01 by قناة التغيير, CC BY 3.0, via Wikimedia Commons
Affordable access, full power:
For just $42 per month, the “Solo” plan unlocks the same API & FDF Intelligence data used by global companies.
You instantly see price ranges, dossiers, and certificates — and, most importantly, gain direct contacts to every manufacturer and FDF holder.
It’s a practical way to work with reliable data without heavy budgets.
Get started today with Solo access →
Get started today with Solo access →
